3) End stage renal disease
终末期肾病
1.
The effect of different dialyzer membranes on IL-18 level in patients with end stage renal diseases;
不同透析膜对终末期肾病患者IL-18水平的影响
2.
Changes of serum fibroblast growth factor 23 in patients with end stage renal disease and its clinical significance;
终末期肾病患者血清成纤维细胞生长因子23的变化及临床意义
3.
Oxidative stress in patients with end stage renal disease and analysis of correlation factors;
终末期肾病患者氧化应激水平及相关因素分析
4) ESRD
终末期肾病
1.
The Apoptosis of Vascular Smooth Muscle Cell and its Influential Factors in ESRD Patients;
终末期肾病患者血管平滑肌细胞凋亡情况及其影响因素分析
2.
Relationship between Metabolism of Pyophosphate and Disorder of Bone and Mineral Metabolism in Patient with ESRD;
终末期肾病焦磷酸盐代谢与骨矿代谢紊乱相关性的研究
3.
Objective Despite improvements in dialysis therapy,the mortality rate of patients with end stage renal disease (ESRD) has remained high.
目的了解终末期肾病患者早期死亡的原因和危险因素。
5) end-stage renal disease
终末期肾病
1.
Application of phosphate binder to end-stage renal disease;
磷结合剂在终末期肾病中的应用
2.
The characterization of Th1 /Th2 profile in end-stage renal disease patients and the correlation with the apoptosis of T lymphocyte;
终末期肾病患者Th1/Th2型细胞因子的特征与外周血T细胞凋亡的关系
3.
Inflammatory status in patients with end-stage renal disease:role of monocyte activation;
单核细胞活化与终末期肾病炎症反应状态的关系
6) 3rd stage of diabetic nephropathy
糖尿病肾病3期
1.
Objective:To observe the effect of Maitongfang(MIF)in treating the 3rd stage of diabetic nephropathy(DN).
目的观察中药脉通方联合西药基础治疗方案治疗糖尿病肾病3期的临床疗效。
2.
Objective : To observe the effect of Mai Tong Fang (MTF) in treating the 3rd stage of diabetic nephropathy(DN).
目的:观察以中药复方脉通方联合西药基础治疗方案治疗糖尿病肾病3期的疗效。
补充资料：糖尿
糖尿
glycosuria
特指葡萄糖尿。正常尿内可有微量葡萄糖，用一般定性方法不能测出。如尿内糖含量增高，用定性方法可以测出时则称为糖尿。其发生原因很多，按其形成机制分：①血糖增高性糖尿，指血中葡萄糖含量增高。同时尿糖排出增加，见于胰岛素分泌不足和生长激素、甲状腺素、肾上腺素、皮质醇等分泌增多，此外肝功能障碍，进食大量碳水化物也可出现糖尿；②血糖正常性糖尿，由于肾小管对葡萄糖的重吸收功能减退而引起的糖尿，又称肾性糖尿，见于家族性糖尿、慢性肾炎和肾病综合征时。其他糖尿，如乳糖、半乳糖、果糖、甘露醇等，当进食过多和体内代谢失调使血中浓度增高时，可出现相当的糖尿，假性糖尿，一些非糖物质如尿酸、维生素C、异烟肼等，在进行尿糖试验时，可具有还原性，尿糖试验呈阳性反应。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条